Health Crisis
Purdue Pharma’s $7B Opioid Settlement Faces Crucial Judicial Review Amid Victims’ Scrutiny
By Economics Desk
|
June 20, 2025
As Purdue Pharma’s $7 billion opioid settlement moves toward a judge’s approval, questions remain about accountability for the Sackler family and whether this deal truly serves the victims of America’s opioid crisis.
This is Exclusive Content for Subscribers
Join our community of patriots to read the full story and get access to all our exclusive analysis.
View Subscription Plans